Mucinous appendiceal neoplasms: classification, imaging, and HIPEC

Recent advances, specifically cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC), offer advantages compared to the traditional therapeutic approach of systemic chemotherapy in the treatment of peritoneal carcinomatosis from mucinous appendiceal neoplasms (MAN). This revi...

Full description

Saved in:
Bibliographic Details
Published in:Abdominal imaging 2019-05, Vol.44 (5), p.1686-1702
Main Authors: Bartlett, David J., Thacker, Paul G., Grotz, Travis E., Graham, Rondell P., Fletcher, Joel G., VanBuren, Wendaline M., Iyer, Veena R., Fidler, Jeff L., Menias, Christine O., Wasif, Nabil, Sheedy, Shannon P.
Format: Article
Language:English
Subjects:
Appendix
Cancer
CHEMOTHERAPY
Classification
Gastric cancer
Gastroenterology
Gastrointestinal cancer
Hepatology
Imaging
Medical imaging
Medicine
Medicine & Public Health
Mens health
Mucoceles
NEOPLASMS
PATIENTS
Peritoneum
Radiology
RADIOLOGY AND NUCLEAR MEDICINE
Review Paper
REVIEWS
SURGERY
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent advances, specifically cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC), offer advantages compared to the traditional therapeutic approach of systemic chemotherapy in the treatment of peritoneal carcinomatosis from mucinous appendiceal neoplasms (MAN). This review provides an up-to-date, comprehensive summary of the histologic classification of MAN, reviews common imaging findings of mucoceles and pseudomyxoma peritonei, and describes the radiologist’s role in the multidisciplinary care team in quantifying disease and in helping select patients for definitive surgery.
ISSN:2366-004X
2366-0058
2366-0058
DOI:10.1007/s00261-018-01888-y